跳转至内容
Merck
CN

SML3776

Sigma-Aldrich

AZD1080

≥98% (HPLC)

别名:

2-Hydroxy-3-[5-(4-morpholinylmethyl)-2-pyridinyl]-1H-indole-5-carbonitrile, 2-Hydroxy-3-[5-[(morpholin-4-yl)methyl]pyridin-2-yl]-1H-indole-5-carbonitrile, AZ1080, AZD 1080

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C19H18N4O2
化学文摘社编号:
分子量:
334.37
MDL编号:
UNSPSC代码:
12352200
NACRES:
NA.21
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

, Faint yellow to yellow brown

溶解性

DMSO: 2 mg/mL, clear

储存温度

-10 to -25°C

SMILES字符串

N4(CCOCC4)Cc1cnc(cc1)c2c3c([nH]c2O)ccc(c3)C#N

InChI

1S/C19H18N4O2/c20-10-13-1-3-16-15(9-13)18(19(24)22-16)17-4-2-14(11-21-17)12-23-5-7-25-8-6-23/h1-4,9,11,22,24H,5-8,12H2

InChI key

BLTVBQXJFVRPFK-UHFFFAOYSA-N

生化/生理作用

AZ1080 is a brain penetrant, orally bioavailable, potent and selective glycogen synthase kinase (GSK3) inhibitor that reduce pcdc1 (PD-1) transcription and expression. AZ1080 enhances CD8+ T-cell function in cancer, and is as effective as ant-PD-1 in controlling of B16 melanoma and EL4 lymphoma growth in mice.
Brain penetrant, orally bioavailable, potent and selective glycogen synthase kinase (GSK3) inhibitor that reduce pcdc1 (PD-1) transcription and expression

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Laura Caberlotto et al.
Naunyn-Schmiedeberg's archives of pharmacology, 386(10), 893-903 (2013-06-25)
Glycogen synthase kinase (GSK3) is a constitutively active serine-threonine kinase associated to neurological and psychiatric disorders. GSK3 inhibition is considered a mediator of the efficacy of the mood-stabiliser lithium. This study aimed at comparing the central nervous system effect of
Alison Taylor et al.
Cancer research, 78(3), 706-717 (2017-10-22)
The impact of PD-1 immune checkpoint therapy prompts exploration of other strategies to downregulate PD-1 for cancer therapy. We previously showed that the serine/threonine kinase, glycogen synthase kinase, GSK-3α/β, is a central regulator of PD-1 transcription in CD8+ T cells.
Shanshan Hu et al.
Neuropsychiatric disease and treatment, 16, 651-663 (2020-03-19)
Parkinson's disease (PD) is the second most common neurodegenerative disease. The α-Synuclein is a major component of Lewy bodies and Lewy neurites, the pathologic hallmark of PD. It is known that α-Synuclein is phosphorylated (p-α-Synuclein) in PD and tau-hyperphosphorylation (p-Tau)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持